Informed consent: A clinical trials perspective

Marilyn J. Hammer, Patricia Eckardt, Margaret Barton-Burke

Research output: Contribution to journalArticlepeer-review

Abstract

The primary goal of the thousands of registered trials in cancer research is to extend survival. With evaluation of efficacy, safety, and tolerability, healthcare providers must ensure that the principles described in the Belmont Report are upheld and that patients are truly informed when signing a consent form. In this article, two cases are highlighted, and reasons for participating in clinical trials are discussed. Challenges, such as healthcare literacy, patients' dedication to their healthcare providers, and choosing between multiple trials, are also explored.

Original languageEnglish (US)
Pages (from-to)694-696
Number of pages3
JournalOncology nursing forum
Volume43
Issue number6
DOIs
StatePublished - Nov 2016

Keywords

  • Biology of cancer
  • Ethics
  • Genetics
  • Nursing research

ASJC Scopus subject areas

  • Oncology(nursing)

Fingerprint Dive into the research topics of 'Informed consent: A clinical trials perspective'. Together they form a unique fingerprint.

Cite this